マーケットレポート詳細
お問い合わせは、アイコンをクリックしてご入力ください。別タブでフォームが開きます。
当レポートの更新版の制作依頼、部分購入やご希望情報の追加等、ご相談可能です。
オメガ3脂肪酸の世界市場規模は2024年の75億ドルから、2029年までに141億ドルへと拡大し、市場の平均年成長率は13.4%で推移することが見込まれています。
レポートはオメガ3脂肪酸の世界市場について2029年までの市場予測データ(金額US$、量ベースKiloton)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(タイプ別市場、原料別市場、等)を中心に構成されています。また競合状況、主要企業情報(15社)、市場ダイナミクス、バリューチェーン分析などの分析も加味し、オメガ3脂肪酸市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆オメガ3脂肪酸の世界市場予測2019-2029年
・市場規模(US$)
・量ベース(Kiloton)
◆タイプ別、市場-2029年
・ドコサヘキサエン酸(DHA)
・エイコサペンタエン酸(EPA)
・α-リノレン酸(ALA)
※(市場規模US$)
◆原料別、市場-2029年
・海洋由来
・植物由来
※(市場規模US$、量ベースKiloton)
◆用途別、市場-2029年
・栄養補助食品
・機能性食品/飲料
・医薬品
・乳児用調製粉乳
・ペットフード/飼料
※(市場規模US$)
◆主要国地域別市場-2029年
北米
・米国、カナダ、メキシコ
欧州
・ドイツ、英国、フランス、ノルウェー、イタリア
・スペイン、オランダ
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア、ニュージーランド
・その他アジア太平洋
南米
・ブラジル、アルゼンチン
・その他南米
その他地域
・アフリカ
-南アフリカ、エジプト、ナイジェリア
-その他アフリカ
・中東
-サウジアラビア、UAE、カタール
-その他中東
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(促進要因、障壁、機会、課題)
・バリューチェーン分析
・エコシステム分析
・貿易分析
・価格分析
・規制の状況
・業界構造分析(ファイブフォース分析)
・主要なステークホルダーと購買基準
・競合状況
・市場シェア分析
◆オメガ3脂肪酸の主要企業プロフィール動向
・BASF SE
・CARGILL, INCORPORATED
・DSM-FIRMENICH
・ADM
・KERRY GROUP PLC
・CRODA INTERNATIONAL PLC
・ORKLA
・CORBION
・PELAGIA AS
・KD PHARMA GROUP SA
・GC RIEBER
・COOKE AQUACULTURE INC.
・ALGISYS BIOSCIENCES, INC.
・GOLDEN OMEGA
・POLARIS
(その他企業)
・BTSA
・FARBEST BRANDS
・KINOMEGA BIOPHARM INC.
・PHARMA MARINE AS
・RIMFROST AS
・ALGARITHM
・SOLUTEX
・CELLANA INC.
・SINOMEGA BIOTECH ENGINEERING CO., LTD.
・ALGAECYTES
(全299頁)
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 STUDY SCOPE 40
1.3.1 MARKET SEGMENTATION 40
1.3.2 INCLUSIONS AND EXCLUSIONS 40
1.3.3 REGIONAL SCOPE 41
1.4 YEARS CONSIDERED 42
1.5 UNITS CONSIDERED 42
1.5.1 CURRENCY CONSIDERED 42
・ TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018–2023 43
1.5.2 VOLUME UNIT 43
1.6 STAKEHOLDERS 43
1.7 SUMMARY OF CHANGES 44
1.7.1 RECESSION IMPACT 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
・ FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 KEY DATA FROM SECONDARY SOURCES 46
2.1.2 PRIMARY DATA 46
2.1.2.1 KEY INDUSTRY INSIGHTS 47
2.1.2.2 LIST OF KEY PARTICIPANTS IN PRIMARY INTERVIEWS 47
2.1.2.3 BREAKDOWN OF PRIMARY INTERVIEWS 48
2.2 MARKET SIZE ESTIMATION 48
2.2.1 BOTTOM-UP APPROACH 49
・ FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION 49
2.2.2 TOP-DOWN APPROACH 50
2.2.2.1 APPROACH TO ESTIMATE MARKET SIZE USING TOP-DOWN ANALYSIS 50
・ FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION 50
・ FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE 51
2.3 DATA TRIANGULATION 52
・ FIGURE 5 DATA TRIANGULATION 52
2.4 RESEARCH ASSUMPTIONS 53
2.5 LIMITATIONS AND RISK ASSESSMENT 53
2.6 RECESSION IMPACT ANALYSIS 54
2.6.1 RECESSION MACROINDICATORS 54
・ FIGURE 6 INDICATORS OF RECESSION 54
・ FIGURE 7 GLOBAL INFLATION RATE, 2011–2022 54
・ FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION) 55
・ FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET 56
・ FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST 56
3 EXECUTIVE SUMMARY 58
・ TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029 58
・ FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 59
・ FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 59
・ FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 60
・ FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023 60
4 PREMIUM INSIGHTS 62
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 62
・ FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH 62
4.2 OMEGA-3 MARKET IN ASIA PACIFIC, BY TYPE AND KEY COUNTRIES 62
・ FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023 62
4.3 OMEGA-3 MARKET, BY APPLICATION 63
・ FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63
4.4 OMEGA-3 MARKET, BY TYPE 63
・ FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029 63
4.5 OMEGA-3 MARKET, BY SOURCE 64
・ FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MACROECONOMIC INDICATORS 65
5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE 65
・ FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2020 66
5.2.2 GROWING GERIATRIC POPULATION 66
・ FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012–2022 67
5.3 MARKET DYNAMICS 67
・ FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET 67
5.3.1 DRIVERS 68
5.3.1.1 GROWING CONSUMER AWARENESS REGARDING HEALTH BENEFITS OF OMEGA-3 68
・ TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION 68
5.3.1.2 INCREASING USE OF OMEGA-3 FATTY ACIDS IN FOOD AND FEED PRODUCTS 69
5.3.1.2.1 RISING DEMAND FOR MOTHER & INFANT NUTRITION PRODUCTS 69
・ TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM) 69
5.3.1.2.2 GROWTH FOCUS OF FOOD PROCESSING COMPANIES ON FORTIFICATION 70
5.3.1.2.3 INCREASING APPLICATIONS IN PET FOOD AND FEED 70
・ FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG) 71
5.3.1.3 GROWING ADOPTION OF INNOVATIVE PRODUCTION TECHNOLOGIES 71
5.3.2 RESTRAINTS 73
5.3.2.1 LOWER FISH OIL SUPPLY DUE TO SUSTAINABILITY ISSUES AMONG FISHERIES 73
5.3.2.2 LACK OF CLARITY AMONG CONSUMERS ABOUT DAILY RECOMMENDED INTAKE AND HEALTH CLAIMS 73
・ TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS 74
5.3.3 OPPORTUNITIES 74
5.3.3.1 INCREASING RESEARCH FOR DEVELOPMENT OF ALTERNATIVE SOURCES TO OBTAIN OMEGA-3 74
・ TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 75
5.3.3.1.1 RISING CONSUMER DEMAND FOR PLANT-BASED PRODUCTS 75
5.3.3.1.1.1 GROWING FOCUS ON MICROALGAE-BASED OMEGA-3 PRODUCTION 76
・ FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3 76
5.3.3.1.1.2 SIDE-EFFECTS AND ALLERGIES RELATED TO FISH-BASED PRODUCTS 77
5.3.3.2 FAVORABLE REGULATORY ENVIRONMENT 77
5.3.3.3 APPLICATION OF MICROENCAPSULATION TECHNOLOGY TO REGULATE RELEASE OF NUTRIENTS IN FORTIFIED FOOD & BEVERAGES 77
5.3.4 CHALLENGES 78
5.3.4.1 HIGH COSTS INVOLVED IN R&D ACTIVITIES 78
5.3.4.2 HIGHLY UNS・ TABLE FISH OIL PRICES 78
5.3.4.3 INSTABILITY OF OMEGA-3 OILS 79
5.4 INVESTMENT AND FUNDING SCENARIO 79
・ FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING 79
6 INDUSTRY TRENDS 80
6.1 INTRODUCTION 80
6.2 VALUE CHAIN ANALYSIS 80
6.2.1 RESEARCH & PRODUCT DEVELOPMENT 80
6.2.2 MANUFACTURING 80
6.2.3 MARKETING & SALES 81
6.2.4 DISTRIBUTION 81
6.2.5 POST-SALES SERVICES 81
・ FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS 82
6.3 TECHNOLOGY ANALYSIS 82
6.3.1 MOLECULAR DISTILLATION 82
6.3.2 ALGAE FERMENTATION 82
6.4 PATENT ANALYSIS 83
・ FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024 83
・ FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET,
2014–2024 84
6.4.1 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET (2014–2023) 84
6.5 ECOSYSTEM ANALYSIS 86
6.5.1 DEMAND SIDE 86
6.5.2 SUPPLY SIDE 86
・ TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM 86
・ FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS 87
6.6 TRADE ANALYSIS 88
6.6.1 EXPORT DATA 88
・ TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION) 88
6.6.2 IMPORT DATA 88
・ TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION) 88
6.7 PRICING ANALYSIS 89
6.7.1 AVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE 89
・ TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG) 89
6.7.2 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCE 89
・ TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3, BY SOURCE, 2019–2023 (USD/KG) 89
6.7.3 AVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGION 89
・ TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES, BY REGION, 2019–2023 (USD/KG) 89
6.7.4 AVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION 90
・ TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES, BY REGION, 2019–2023 (USD/KG) 90
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 90
・ FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET 90
6.9 KEY CONFERENCES AND EVENTS, 2024 91
・ TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023–2024 91
6.10 REGULATORY LANDSCAPE 92
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
・ TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
・ TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
・ TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
6.10.2 REGULATORY LANDSCAPE 93
6.10.2.1 NORTH AMERICA 93
6.10.2.1.1 US 93
6.10.2.1.2 CANADA 94
6.10.2.2 EUROPE 94
6.10.2.3 ASIA PACIFIC 94
6.10.2.3.1 CHINA 94
6.10.2.3.2 JAPAN 95
6.10.2.3.3 INDIA 95
6.10.2.4 SOUTH AMERICA 95
6.10.2.4.1 BRAZIL 95
6.10.2.4.2 ARGENTINA 96
6.10.2.4.3 CHILE 96
6.10.2.5 ROW 96
6.10.2.5.1 SOUTH AFRICA 96
6.10.2.5.2 UAE 96
6.11 CASE STUDY ANALYSIS 97
6.11.1 VERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAE 97
6.11.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 98
6.11.3 OMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY 98
6.12 PORTER'S FIVE FORCES ANALYSIS 99
・ TABLE 18 PORTER'S FIVE FORCES ANALYSIS 99
6.12.1 INTENSITY OF COMPETITIVE RIVALRY 99
6.12.2 BARGAINING POWER OF SUPPLIERS 99
6.12.3 BARGAINING POWER OF BUYERS 99
6.12.4 THREAT OF SUBSTITUTES 100
6.12.5 THREAT OF NEW ENTRANTS 100
6.13 KEY STAKEHOLDERS & BUYING CRITERIA 101
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 101
・ FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE 101
・ TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%) 101
6.13.2 BUYING CRITERIA 102
・ FIGURE 32 BUYING CRITERIA 102
・ TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT 102
7 OMEGA-3 MARKET, BY TYPE 103
7.1 INTRODUCTION 104
・ FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD 104
・ TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 104
・ TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 105
7.2 DOCOSAHEXAENOIC ACID 105
7.2.1 LOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH 105
・ TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING) 105
・ TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 106
・ TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 106
7.3 EICOSAPENTAENOIC ACID 106
7.3.1 REDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND 106
・ TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING) 107
・ TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 107
・ TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 107
7.4 ALPHA-LINOLENIC ACID 108
7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND 108
・ TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING) 108
・ TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 108
・ TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 109
8 OMEGA-3 MARKET, BY SOURCE 110
8.1 INTRODUCTION 111
・ FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 111
・ TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 111
・ TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 112
・ TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 112
・ TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 112
8.2 MARINE 112
8.2.1 SURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET 112
・ TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS 113
・ TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 114
・ TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 114
・ TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT) 114
・ TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT) 115
・ TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION) 115
・ TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION) 115
8.3 PLANT 116
8.3.1 GROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND 116
・ TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 116
・ TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 117
・ TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT) 117
・ TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT) 117
・ TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION) 118
・ TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION) 118
9 OMEGA-3 MARKET, BY APPLICATION 119
9.1 INTRODUCTION 120
・ FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 120
・ TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 120
・ TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 121
9.2 DIETARY SUPPLEMENT 121
9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET 121
・ TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 121
・ TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 122
9.3 FUNCTIONAL FOOD & BEVERAGE 122
9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND 122
・ TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 123
・ TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 123
9.4 PHARMACEUTICAL 123
9.4.1 GROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET 123
・ TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 124
・ TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 124
9.5 INFANT FORMULA 124
9.5.1 RISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND 124
・ TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 125
・ TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 125
9.6 PET FOOD AND FEED 125
9.6.1 GREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET 125
・ TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 126
・ TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 126
10 OMEGA-3 MARKET, BY REGION 127
10.1 INTRODUCTION 128
・ FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET 129
・ TABLE 61 OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 129
・ TABLE 62 OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 130
・ TABLE 63 OMEGA-3 MARKET, BY REGION, 2019–2023 (KT) 130
・ TABLE 64 OMEGA-3 MARKET, BY REGION, 2024–2029 (KT) 130
10.2 NORTH AMERICA 131
・ FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT 132
10.2.1 NORTH AMERICA: RECESSION IMPACT 132
・ FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS 133
・ TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 133
・ TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 134
・ TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 134
・ TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 134
・ TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 134
・ TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 135
・ TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 135
・ TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 135
・ TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 135
・ TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 136
10.2.2 US 136
10.2.2.1 GROWING DEMAND FOR PLANT-BASED OMEGA-3 DIETARY SUPPLEMENTS TO DRIVE MARKET 136
・ TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 137
・ TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 137
・ TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 137
・ TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 138
・ TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 138
・ TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 138
・ TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 138
10.2.3 CANADA 139
10.2.3.1 INCREASED APPLICATION IN FUNCTIONAL FOOD & BEVERAGES TO BOOST DEMAND 139
・ TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 139
・ TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 139
・ TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 140
・ TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 140
・ TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 140
・ TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 140
・ TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 141
10.2.4 MEXICO 141
10.2.4.1 GROWING FOCUS ON PREVENTING HEART DISEASES TO DRIVE MARKET 141
・ TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 141
・ TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 142
・ TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 142
・ TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 142
・ TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 142
・ TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 143
10.3 EUROPE 143
10.3.1 EUROPE: RECESSION IMPACT 143
・ FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS 144
・ TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 144
・ TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 145
・ TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 145
・ TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 145
・ TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 146
・ TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 146
・ TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 146
・ TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 146
・ TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 147
・ TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 147
10.3.2 GERMANY 147
10.3.2.1 LESS FISH CONSUMPTION TO BOOST DEMAND FOR OMEGA-3-BASED SUPPLEMENTS 147
・ TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 147
・ TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 148
・ TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 148
・ TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 148
・ TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 149
・ TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 149
・ TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 149
10.3.3 UK 149
10.3.3.1 ABILITY TO BOOST BRAIN FUNCTION AND REDUCE INFLAMMATION TO DRIVE MARKET 149
・ TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 150
・ TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 150
・ TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 151
・ TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 151
・ TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 151
・ TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 151
・ TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 152
10.3.4 FRANCE 152
10.3.4.1 ONGOING INNOVATIONS TO BOOST QUALITY AND STABILITY OF OMEGA-3-RICH OILS FORMULATION TO DRIVE MARKET 152
・ TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 152
・ TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 153
・ TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 153
・ TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 153
・ TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 154
・ TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 154
・ TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 154
10.3.5 NORWAY 154
10.3.5.1 PRODUCTION OF GENETICALLY MODIFIED CANOLA TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS 154
・ TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 155
・ TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 155
・ TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 155
・ TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 156
・ TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 156
・ TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 156
10.3.6 ITALY 156
10.3.6.1 HIGH PRODUCTION OF DIETARY SUPPLEMENTS, FUNCTIONAL FOOD PRODUCTS, AND BEVERAGES TO BOOST DEMAND 156
・ TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 157
・ TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 157
・ TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 157
・ TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 158
・ TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 158
・ TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 158
10.3.7 SPAIN 158
10.3.7.1 NEED FOR SUFFICIENT CONSUMPTION OF ALA, DHA AND EPA FROM FOODS TO ACCELERATE DEMAND 158
・ TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 159
・ TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 159
・ TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 159
・ TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 159
・ TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 160
・ TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 160
・ TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 160
10.3.8 NETHERLANDS 160
10.3.8.1 GROWING INCIDENCES OF DEPRESSION, AUTISM, AND ADHD TO DRIVE MARKET 160
・ TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 161
・ TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 161
・ TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 161
・ TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 161
・ TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 162
・ TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 162
・ TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 162
10.3.9 REST OF EUROPE 162
・ TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 163
・ TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 163
・ TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 163
・ TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 164
・ TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 164
・ TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 164
・ TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 164
10.4 ASIA PACIFIC 165
・ FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT 166
10.4.1 ASIA PACIFIC: RECESSION IMPACT 166
・ FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS 167
・ TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 168
・ TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 168
・ TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 168
・ TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 169
・ TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 169
・ TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 169
・ TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 169
・ TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 170
・ TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 170
・ TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 170
10.4.2 CHINA 170
10.4.2.1 INCREASING FOCUS ON PRODUCT INNOVATIONS AND DIVERSIFICATIONS TO DRIVE MARKET 170
・ TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 171
・ TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 171
・ TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 171
・ TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 171
・ TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 172
・ TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 172
・ TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 172
10.4.3 INDIA 172
10.4.3.1 GROWING INCIDENCES OF HEART FAILURE TO DRIVE MARKET 172
・ TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 173
・ TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 173
・ TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 173
・ TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 173
・ TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 174
・ TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 174
・ TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 174
10.4.4 JAPAN 174
10.4.4.1 RISING USE OF INNOVATIVE FORMULATION TECHNOLOGY TO CREATE OPPORTUNITIES FOR MANUFACTURERS OF OMEGA-3 PRODUCTS 174
・ TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 175
・ TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 175
・ TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 175
・ TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 175
・ TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 176
・ TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 176
・ TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 176
10.4.5 AUSTRALIA 176
10.4.5.1 GOVERNMENT-LED INITIATIVES TO INCREASE AWARENESS REGARDING OMEGA-3 TO DRIVE MARKET 176
・ TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 177
・ TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 177
・ TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 177
・ TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 178
・ TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 178
・ TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 178
・ TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 178
10.4.6 NEW ZEALAND 179
10.4.6.1 INCREASING CONSUMER AWARENESS AND GOVERNMENT REGULATIONS FOR OMEGA-3 SUPPLEMENTS TO DRIVE MARKET GROWTH 179
・ TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 179
・ TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 179
・ TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 180
・ TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 180
・ TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 180
・ TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 180
・ TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 181
10.4.7 REST OF ASIA PACIFIC 181
・ TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3 181
・ TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 182
・ TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 182
・ TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 182
・ TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 183
・ TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 183
・ TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 183
10.5 SOUTH AMERICA 184
10.5.1 SOUTH AMERICA: RECESSION IMPACT 184
・ FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023 185
・ TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 185
・ TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 185
・ TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 186
・ TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 186
・ TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 186
・ TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 187
・ TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 187
・ TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 187
・ TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 187
・ TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 188
10.5.2 BRAZIL 188
10.5.2.1 RISING DEMAND FOR ALGAL OILS TO DRIVE MARKET 188
・ TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 188
・ TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 189
・ TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 189
・ TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 189
・ TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 189
・ TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 190
10.5.3 ARGENTINA 190
10.5.3.1 COMMERCIALIZATION OF OMEGA-3 PRODUCTS TO FUEL MARKET GROWTH 190
・ TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 190
・ TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 191
・ TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 191
・ TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 191
・ TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 191
・ TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 192
10.5.4 REST OF SOUTH AMERICA 192
・ TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 192
・ TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 192
・ TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 193
・ TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 193
・ TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 193
・ TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 193
10.6 ROW 194
10.6.1 ROW: RECESSION IMPACT 194
・ FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS 194
・ TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION) 195
・ TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION) 195
・ TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 195
・ TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 195
・ TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 196
・ TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 196
・ TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 196
・ TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 196
・ TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT) 197
・ TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT) 197
10.6.2 AFRICA 197
・ TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 198
・ TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 198
・ TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 198
・ TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 199
・ TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 199
・ TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 199
・ TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 199
・ TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 200
10.6.2.1 SOUTH AFRICA 200
10.6.2.1.1 PREVALENCE OF UNDERNUTRITION AMONG PREGNANT WOMEN AND KIDS TO DRIVE DEMAND 200
・ TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 200
・ TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 201
・ TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 201
・ TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 201
・ TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 201
・ TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 202
10.6.2.2 EGYPT 202
10.6.2.2.1 IMPROVED PEDIATRIC HEALTH CONDITIONS TO BOOST DEMAND 202
・ TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 202
・ TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 202
・ TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 203
・ TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 203
・ TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 203
・ TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 203
10.6.2.3 NIGERIA 204
10.6.2.3.1 RISING PREVALNCE OF ARTERY DISEASES TO BOOST DEMAND 204
・ TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 204
・ TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 205
・ TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 205
・ TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 205
・ TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 205
・ TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 206
10.6.2.4 REST OF AFRICA 206
・ TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 206
・ TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 207
・ TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 207
・ TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 207
・ TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 207
・ TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 208
10.6.3 MIDDLE EAST 208
・ TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 208
・ TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 209
・ TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 209
・ TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 209
・ TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 210
・ TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 210
・ TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 210
・ TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 210
10.6.3.1 SAUDI ARABIA 211
10.6.3.1.1 ONGOING INNOVATIONS IN OMEGA-3 PRODUCTS TO DRIVE MARKET 211
・ TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 211
・ TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 211
・ TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 212
・ TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 212
・ TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 212
・ TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 212
10.6.3.2 UAE 213
10.6.3.2.1 INCREASING AWARENESS AMONG CONSUMERS ABOUT HEALTH PRODUCTS TO DRIVE MARKET 213
・ TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 213
・ TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 213
・ TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 214
・ TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 214
・ TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 214
・ TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 214
10.6.3.3 QATAR 215
10.6.3.3.1 GROWING RESEARCH ON ALGAE TO BOOST DEMAND 215
・ TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 215
・ TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 215
・ TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 216
・ TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 216
・ TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 216
・ TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 216
10.6.3.4 REST OF MIDDLE EAST 217
・ TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 217
・ TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 217
・ TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION) 218
・ TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION) 218
・ TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION) 218
・ TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 218
11 COMPETITIVE LANDSCAPE 219
11.1 OVERVIEW 219
11.2 MARKET SHARE ANALYSIS, 2022 219
・ TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION 220
11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020–2024 220
・ TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020–2024 220
11.4 BRAND/PRODUCT ANALYSIS 223
・ FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS 223
11.5 SEGMENTAL REVENUE ANALYSIS, 2020–2022 224
・ FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION) 224
11.6 KEY PLAYERS’ ANNUAL REVENUE, 2022 VS. REVENUE GROWTH, 2020–2022 225
・ FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%), 2020–2022 225
11.7 EBIT/EBITDA ANALYSIS, 2022 226
・ FIGURE 47 EBIT/EBITDA (USD BILLION) 226
11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022 226
・ FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS 226
11.9 COMPANY VALUATION AND FINANCIAL METRICS 227
・ FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES 227
・ FIGURE 50 EV/EBITDA OF KEY COMPANIES 227
11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022 228
11.10.1 STARS 228
11.10.2 EMERGING LEADERS 228
11.10.3 PERVASIVE PLAYERS 228
11.10.4 PARTICIPANTS 228
・ FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 229
11.10.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 230
11.10.5.1 COMPANY FOOTPRINT 230
・ TABLE 315 OVERALL COMPANY FOOTPRINT 230
11.10.5.2 TYPE FOOTPRINT 231
・ TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT 231
11.10.5.3 SOURCE FOOTPRINT 232
・ TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT 232
11.10.5.4 APPLICATION FOOTPRINT 233
・ TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT 233
11.10.5.5 REGION FOOTPRINT 234
・ TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT 234
11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022 234
11.11.1 PROGRESSIVE COMPANIES 234
11.11.2 RESPONSIVE COMPANIES 234
11.11.3 DYNAMIC COMPANIES 235
11.11.4 STARTING BLOCKS 235
・ FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022 235
11.11.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023 236
11.11.5.1 LIST OF KEY START-UPS/SMES 236
・ TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES 236
11.11.5.2 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 237
・ TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 237
11.12 COMPETITIVE SCENARIO 238
11.12.1 PRODUCT LAUNCHES 238
・ TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020– FEBRUARY 2024 238
11.12.2 DEALS 239
・ TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020– FEBRUARY 2024 239
11.12.3 EXPANSIONS 241
・ TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020– FEBRUARY 2024 241
11.12.4 OTHERS 242
・ TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020– FEBRUARY 2024 242
12 COMPANY PROFILES 243
(BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1 KEY PLAYERS 243
12.1.1 BASF SE 243
・ TABLE 326 BASF SE: COMPANY OVERVIEW 243
・ FIGURE 53 BASF SE: COMPANY SNAPSHOT 244
・ TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244
・ TABLE 328 BASF SE: PRODUCT LAUNCHES 246
12.1.2 CARGILL, INCORPORATED 247
・ TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW 247
・ FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT 247
・ TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
・ TABLE 331 CARGILL, INCORPORATED: DEALS 248
12.1.3 DSM-FIRMENICH 250
・ TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW 250
・ FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT 251
・ TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 251
・ TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES 252
12.1.4 ADM 253
・ TABLE 335 ADM: COMPANY OVERVIEW 253
・ FIGURE 56 ADM: COMPANY SNAPSHOT 254
・ TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254
12.1.5 KERRY GROUP PLC 256
・ TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW 256
・ FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT 257
・ TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257
・ TABLE 339 KERRY GROUP PLC: DEALS 258
12.1.6 CRODA INTERNATIONAL PLC 259
・ TABLE 340 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 259
・ FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 260
・ TABLE 341 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260
12.1.7 ORKLA 262
・ TABLE 342 ORKLA: COMPANY OVERVIEW 262
・ FIGURE 59 ORKLA: COMPANY SNAPSHOT 263
・ TABLE 343 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 263
・ TABLE 344 ORKLA: DEALS 264
12.1.8 CORBION 265
・ TABLE 345 CORBION: COMPANY OVERVIEW 265
・ FIGURE 60 CORBION: COMPANY SNAPSHOT 266
・ TABLE 346 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 266
・ TABLE 347 CORBION: PRODUCT LAUNCHES 267
・ TABLE 348 CORBION: EXPANSIONS 267
12.1.9 PELAGIA AS 268
・ TABLE 349 PELAGIA AS: COMPANY OVERVIEW 268
・ FIGURE 61 PELAGIA AS: COMPANY SNAPSHOT 269
・ TABLE 350 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
・ TABLE 351 PELAGIA AS: DEALS 270
12.1.10 KD PHARMA GROUP SA 271
・ TABLE 352 KD PHARMA GROUP SA: COMPANY OVERVIEW 271
・ TABLE 353 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 271
・ TABLE 354 KD PHARMA GROUP SA: EXPANSIONS 272
12.1.11 GC RIEBER 274
・ TABLE 355 GC RIEBER: COMPANY OVERVIEW 274
・ TABLE 356 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 274
・ TABLE 357 GC RIEBER: PRODUCT LAUNCHES 275
・ TABLE 358 GC REIBER: DEALS 275
・ TABLE 359 GC RIEBER: EXPANSIONS 275
12.1.12 COOKE AQUACULTURE INC. 277
・ TABLE 360 COOKE AQUACULTURE INC.: COMPANY OVERVIEW 277
・ TABLE 361 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 277
・ TABLE 362 COOKE AQUACULTURE INC.: DEALS 278
12.1.13 ALGISYS BIOSCIENCES, INC. 279
・ TABLE 363 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW 279
・ TABLE 364 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 279
・ TABLE 365 ALGISYS BIOSCIENCES, INC.: OTHERS 280
12.1.14 GOLDEN OMEGA 281
・ TABLE 366 GOLDEN OMEGA: COMPANY OVERVIEW 281
・ TABLE 367 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
・ TABLE 368 GOLDEN OMEGA: DEALS 282
12.1.15 POLARIS 283
・ TABLE 369 POLARIS: COMPANY OVERVIEW 283
・ TABLE 370 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283
・ TABLE 371 POLARIS: PRODUCT LAUNCHES 284
・ TABLE 372 POLARIS: OTHERS 284
12.2 OTHER PLAYERS 285
12.2.1 BTSA 285
・ TABLE 373 BTSA: COMPANY OVERVIEW 285
・ TABLE 374 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
12.2.2 FARBEST BRANDS 287
・ TABLE 375 FARBEST BRANDS: COMPANY OVERVIEW 287
・ TABLE 376 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287
12.2.3 KINOMEGA BIOPHARM INC. 289
・ TABLE 377 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW 289
・ TABLE 378 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 289
12.2.4 PHARMA MARINE AS 291
・ TABLE 379 PHARMA MARINE AS: COMPANY OVERVIEW 291
・ TABLE 380 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 291
12.2.5 RIMFROST AS 293
・ TABLE 381 RIMFROST AS: COMPANY OVERVIEW 293
・ TABLE 382 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 293
・ TABLE 383 RIMFROST AS: DEALS 294
12.2.6 ALGARITHM 295
12.2.7 SOLUTEX 295
12.2.8 CELLANA INC. 296
12.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD 296
12.2.10 ALGAECYTES 297
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 ADJACENT AND RELATED MARKETS 298
13.1 INTRODUCTION 298
・ TABLE 384 ADJACENT MARKETS 298
13.2 LIMITATIONS 298
13.3 COLLAGEN MARKET 298
13.3.1 MARKET DEFINITION 298
13.3.2 MARKET OVERVIEW 299
・ TABLE 385 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION) 299
・ TABLE 386 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION) 299
13.4 ALGAE PRODUCTS MARKET 300
13.4.1 MARKET DEFINITION 300
13.4.2 MARKET OVERVIEW 300
・ TABLE 387 ALGAE PRODUCTS MARKET, BY SOURCE, 2018–2022 (USD MILLION) 300
・ TABLE 388 ALGAE PRODUCTS MARKET, BY SOURCE, 2023–2028 (USD MILLION) 301
14 APPENDIX 302
14.1 DISCUSSION GUIDE 302
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 307
14.3 CUSTOMIZATION OPTIONS 309
14.4 RELATED REPORTS 309
14.5 AUTHOR DETAILS 310